Cholesterol | Page 36 of 55

Consumer-driven health plans slow to catch on, 2nd annual survey finds

Americans have not yet warmed to consumer-driven health plans, a relatively new kind of coverage that offers reduced premiums but carries higher annual deductibles. Enrollment in consumer-driven plans remains low, and satisfaction continues to lag when compared with more comprehensive health insurance, according to a survey released today by the Employee Benefit Research Institute and the Commonwealth Fund, nonpartisan organizations.

Weight Loss :: Blacks less likely to recognize overweight and obesity

Overweight black Americans are two to three times more likely than heavy white Americans to say they are of average weight — even after being diagnosed as overweight or obese by their doctors, according to a study led by Dana-Farber Cancer Institute researchers.

Imaging :: PET imaging shows young smokers quick benefit of quitting

The early stages of coronary artery disease in young smokers can be reversed quickly if they choose to put out their cigarettes for good, according to a positron emission tomography (PET) imaging study in the December Journal of Nuclear Medicine.

Heart Disease :: Screening children for heart disease risk helps to identify parents at risk

Screening children for risk factors associated with cardiovascular disease can help identify parents at risk for the condition, providing an opportunity for medical intervention in both children and their parents, according to research at Children’s Hospital of Pittsburgh of UPMC.

Alzheimer’s Disease :: Scientists develop a new way to target Alzheimer’s disease

A group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins.

Cholesterol :: Cardiologists will embrace HDL raising drugs

A survey conducted anonymously for Reuters Primary Research revealed that the cardiologists are ready to embrace medicines like statins that raise levels of good cholesterol HDL to reduce the risk of coronary artery diseases.

Huntington’s Disease :: Mayo discovers link between Huntington’s and abnormal cholesterol levels in brain

Mayo Clinic researchers have discovered a protein interaction that may explain how the deadly Huntington’s disease affects the brain. The findings, published in and featured on the cover of the current issue of Human Molecular Genetics, show how the mutated Huntington’s protein interacts with another protein to cause dramatic accumulation of cholesterol in the brain.

Cancer :: What cures your aches might prevent cancer

Mayo Clinic Cancer Center has begun three clinical studies looking at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent cancer — colon, esophageal or lung.

Parkinson’s Disease :: Less risk of Parkinson’s disease with increased cholesterol

Women with higher levels of total cholesterol appear to be at decreased risk for developing Parkinson’s disease, according to a report by researchers in the Netherlands. The study is published in American Journal of Epidemiology, November 2006 issue.

Diabetes :: Patient Support Program Offers Savings on Glumetza Therapy for Type 2 Diabetes

King Pharmaceuticals, Inc. (NYSE: KG) and Depomed, Inc. (NASDAQ: DEPO) today announced the launch of a new program that will provide support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets), a new once-daily extended-release metformin formulation that features AcuForm drug-delivery technology.